Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the ‘FC Prostate’ randomized controlled trial

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the ‘FC Prostate’ randomized controlled trial ; volume:13 ; number:1 ; day:13 ; month:12 ; year:2013 ; pages:1-10 ; date:12.2013
BMC cancer ; 13, Heft 1 (13.12.2013), 1-10, 12.2013

Creator
Uth, Jacob
Contributor
Schmidt, Jakob Friis
Christensen, Jesper Frank
Hornstrup, Therese
Andersen, Lars Juel
Hansen, Peter Riis
Christensen, Karl Bang
Andersen, Lars Louis
Helge, Eva Wulff
Brasso, Klaus
RøRth, Mikael
Krustrup, Peter
Midtgaard, Julie
SpringerLink (Online service)

DOI
10.1186/1471-2407-13-595
URN
urn:nbn:de:1111-201603048429
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Uth, Jacob
  • Schmidt, Jakob Friis
  • Christensen, Jesper Frank
  • Hornstrup, Therese
  • Andersen, Lars Juel
  • Hansen, Peter Riis
  • Christensen, Karl Bang
  • Andersen, Lars Louis
  • Helge, Eva Wulff
  • Brasso, Klaus
  • RøRth, Mikael
  • Krustrup, Peter
  • Midtgaard, Julie
  • SpringerLink (Online service)

Other Objects (12)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer

Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer

Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer

Androgen deprivation in prostate cancer: benefits of home-based resistance training

Androgen deprivation in prostate cancer: benefits of home-based resistance training

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer

Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy

Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer

Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?

Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Bone mineral density in Jamaican men on androgen deprivation therapy for prostate cancer

Bone mineral density in Jamaican men on androgen deprivation therapy for prostate cancer

An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer

An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer

Docetaxel in the management of PSA progression following primary androgen deprivation for prostate cancer

Hochschulschrift

Docetaxel in the management of PSA progression following primary androgen deprivation for prostate cancer

Related objects